Group One Trading’s Acceleron Pharma XLRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-21,002
| Closed | -$3.61M | – | 9192 |
|
|
2021
Q3 | $3.61M | Buy |
+21,002
| New | +$2.75M | ﹤0.01% | 2037 |
|
|
2021
Q1 | – | Sell |
-280
| Closed | -$36.2K | – | 8234 |
|
|
2020
Q4 | $36K | Buy |
+280
| New | +$32.8K | ﹤0.01% | 5210 |
|
|
2019
Q2 | – | Sell |
-7,269
| Closed | -$301K | – | 5603 |
|
|
2019
Q1 | $339K | Sell |
7,269
-279
| -4% | -$12.3K | ﹤0.01% | 2261 |
|
|
2018
Q4 | $329K | Buy |
+7,548
| New | +$377K | ﹤0.01% | 2304 |
|
|
2017
Q4 | – | Sell |
-3,134
| Closed | -$118K | – | 5401 |
|
|
2017
Q3 | $117K | Buy |
+3,134
| New | +$109K | ﹤0.01% | 3136 |
|
|
2016
Q2 | – | Sell |
-561
| Closed | -$18.2K | – | 5071 |
|
|
2016
Q1 | $15K | Buy |
561
+500
| +820% | +$14.5K | ﹤0.01% | 3885 |
|
|
2015
Q4 | $3K | Buy |
+61
| New | +$2.19K | ﹤0.01% | 4499 |
|
|
2015
Q2 | – | Sell |
-6,479
| Closed | -$209K | – | 5311 |
|
|
2015
Q1 | $247K | Buy |
+6,479
| New | +$258K | ﹤0.01% | 2214 |
|
|
2014
Q4 | – | Sell |
-200
| Closed | -$6.97K | – | 5420 |
|
|
2014
Q3 | $6K | Buy |
+200
| New | +$5.63K | ﹤0.01% | 4689 |
|
Group One Trading's XLRN Position: Q4 2021 in Review
Group One Trading sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 21,002 shares — an estimated $3.61M sold.
Group One Trading first reported a position in XLRN in Q3 2014 and held it in 9 quarters. The position peaked at $3.61M in Q3 2021. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.
- Group One Trading reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
- Group One Trading sold 21,002 Acceleron Pharma shares in Q4 2021, an estimated $3.61M.
- Group One Trading first reported a position in Acceleron Pharma in Q3 2014 and held it in 9 quarters.
- Group One Trading's Acceleron Pharma position peaked at $3.61M in Q3 2021.
- 1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.
Based on Group One Trading's 13F filing for Q4 2021, filed 11 Feb 2022.